(Q44520957)

3 December 2017

title

Activation of FoxO3a/Bim axis in patients with Primary Biliary Cirrhosis (English)

1 reference

primary biliary cholangitis

3 December 2017

main subject

0 references

author

Malgorzata Milkiewicz

Malgorzata Milkiewicz

8

0 references

Piotr Milkiewicz

Piotr Milkiewicz

7

0 references

Elwyn Elias

4

Elwyn Elias

1 reference

Agnieszka Kempińska-Podhorodecka

3 December 2017

2

Agnieszka Kempińska-Podhorodecka

1 reference

3 December 2017

Justyna Kopycinska

1

1 reference

3 December 2017

Tara Haas

3

1 reference

3 December 2017

Ronald A DePinho

5

1 reference

3 December 2017

Jihye Paik

6

1 reference

3 December 2017

language of work or name

1 reference

1 February 2013

1 reference

3 December 2017

1 reference

3 December 2017

volume

33

1 reference

3 December 2017

issue

2

1 reference

3 December 2017

page(s)

231-238

1 reference

Chemical xenobiotics and mitochondrial autoantigens in primary biliary cirrhosis: identification of antibodies against a common environmental, cosmetic, and food additive, 2-octynoic acid

3 December 2017

cites work

1 reference

Experimental evidence on the immunopathogenesis of primary biliary cirrhosis

21 January 2018

1 reference

Nuclear DNA fragmentation and expression of Bcl-2 in primary biliary cirrhosis

21 January 2018

1 reference

Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells

21 January 2018

1 reference

Comprehensive mapping of HLA-A0201-restricted CD8 T-cell epitopes on PDC-E2 in primary biliary cirrhosis

21 January 2018

1 reference

A brief introduction to FOXOlogy

21 January 2018

1 reference

Forkhead transcription factors and cardiovascular biology

21 January 2018

1 reference

Decisions on life and death: FOXO Forkhead transcription factors are in command when PKB/Akt is off duty

21 January 2018

1 reference

The forkhead transcription factor FoxO regulates transcription of p27Kip1 and Bim in response to IL-2

21 January 2018

1 reference

FoxO3a transcriptional regulation of Bim controls apoptosis in paclitaxel-treated breast cancer cell lines

21 January 2018

1 reference

Bim: a novel member of the Bcl-2 family that promotes apoptosis

21 January 2018

1 reference

BH3-only proteins in apoptosis and beyond: an overview

21 January 2018

1 reference

Bcl-2 functions in an antioxidant pathway to prevent apoptosis

21 January 2018

1 reference

FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis

21 January 2018

1 reference

Identification of a mechanism underlying regulation of the anti-angiogenic forkhead transcription factor FoxO1 in cultured endothelial cells and ischemic muscle

21 January 2018

1 reference

Soluble apoptosis molecules in primary biliary cirrhosis: analysis and commitment of the Fas and tumour necrosis factor-related apoptosis-inducing ligand systems in comparison with chronic hepatitis C.

21 January 2018

1 reference

The proapoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex

21 January 2018

1 reference

Multisite phosphorylation regulates Bim stability and apoptotic activity

21 January 2018

1 reference

Transcriptional regulation of Bim by FoxO3A mediates hepatocyte lipoapoptosis

21 January 2018

1 reference

FKHR-L1 can act as a critical effector of cell death induced by cytokine withdrawal: protein kinase B-enhanced cell survival through maintenance of mitochondrial integrity

21 January 2018

1 reference

Expression of the pro-apoptotic Bcl-2 family member Bim is regulated by the forkhead transcription factor FKHR-L1

21 January 2018

1 reference

FOXO transcription factors directly activate bim gene expression and promote apoptosis in sympathetic neurons

21 January 2018

1 reference

FoxOs in tumor suppression and stem cell maintenance

21 January 2018

1 reference

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis

21 January 2018

1 reference

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/LIV.12030

1 reference

3 December 2017

1 reference